TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MGX

Metagenomi, Inc.

Healthcare · Biotechnology

1.20$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Metagenomi, Inc. (MGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 174 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MGX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
386 365 415 386 358 325 298 272 248 221 197 174
300 278 336 308 282 258 233 212 190 166 145 124
102 141 103 61 25 27 29 27 33 42 25 39
293 271 327 300 275 248 226 205 184 161 140 121
3.9 2.5 2.1 1.6 0.6 1.3 1.0 0.9 1.0 0.3 1.0 0.9
0.0 – 0.0 – – – – – – – – –
505 500 140 116 103 90 85 76 69 63 59 61
69 69 71 53 46 37 40 33 30 23 22 28
2.3 3.4 4.4 5.4 4.7 5.6 5.6 5.5 5.6 6.0 6.1 6.2
4.9 1.8 6.8 3.5 3.1 0.5 2.7 2.9 1.2 1.5 2.4 2.6
-119 -136 276 269 256 235 213 196 178 159 138 113
-126 -145 -170 -181 -200 -223 -248 -268 -288 -311 -334 -361
37 37 37 37 37 37 37 37 37 38 38 38

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?